HELP Cybin Inc.
$12.97▲ +1.01%
Healthcare
Other
After hours
$13.01▲ +0.30%
Sep 11, 7:30 PM ET
Volume 1.15M
Avg Volume (10D) 1.43M
Key Metrics & Fundamentals
Market Cap
$947.59M
P/E Ratio
–
Div Yield
–%
52W Range
3.76 - 14.35
% vs 50 MA
31.66%
% vs 200 MA
88.17%
RSI-14
60.4
MACD Histogram
-0.1200
Beta (1Y vs SPY)
2.14
Free Cash Flow
-$37.39M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$49.03M
COGS
–
Operating Exp
$49.08M
Operating Income
-$49.08M
EBIT
-$49.08M
Pretax Income
-$47.82M
Net Income
-$47.82M
EPS (Diluted)
-0.91
Price & Volume History
Loading chart…
Recent News
Helus Pharma to Participate at the Morgan Stanley 24th Annual Global Healthcare Conference in New York
GlobeNewswire · Sep 10, 2026 11:30 AM
Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York
GlobeNewswire · Sep 9, 2026 11:30 AM
Helus Pharma to Participate at the 2026 Cantor Global Healthcare Conference in New York
GlobeNewswire · Sep 3, 2026 11:30 AM
Cybin (HELP) Gets A Fresh Look On Trial Progress And CEO Change
Simply Wall St. · Aug 26, 2026 2:16 AM
Cybin (CYBN) Stock Sees Fair Value Lift As Sector Research Supports Growth Assumptions
Simply Wall St. · Aug 22, 2026 10:09 AM
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now
Simply Wall St. · Aug 21, 2026 5:16 AM
Helus Pharma Appoints Regina Donohue as Chief People Officer and Suresh Durgam, M.D., to its Scientific Advisory Board
GlobeNewswire · Aug 18, 2026 11:30 AM
Helus Pharma Reports First Quarter Fiscal 2027 Financial Results and Recent Business Highlights
GlobeNewswire · Aug 14, 2026 11:28 AM
Cybin Conference: Helus CEO Eyes Q4 Phase III Depression Data for HLP003
MarketBeat · Aug 14, 2026 11:04 AM
Helus Pharma to Participate at the Canaccord Genuity 46th Annual Growth Conference in Boston
GlobeNewswire · Aug 10, 2026 4:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See HELP's money flow as a full page
Social Sentiment
Avg +0.73 · 3 posts
DDNewsDiscussionCybin D/B/A Helus Pharma ($HELP)
r/wallstreetbets · Aug 6, 2026
The post highlights positive trial results, a new CEO, and potential for a buyout, indicating bullish sentiment.
positive
+0.70
NewsDiscussionDD$HELP - Thoughts?
r/wallstreetbets · Aug 6, 2026
The post highlights strong trial results, a new CEO with a successful track record, and a potential 5x value increase.
positive
+0.70
NewsDiscussionTradeI might need some $HELP after this psychedelic yolo
r/wallstreetbets · Jun 24, 2026
Significant bullish sentiment expressed regarding potential upside and investment strategy.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.